LV10179B - Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them - Google Patents
Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them Download PDFInfo
- Publication number
- LV10179B LV10179B LVP-93-1379A LV931379A LV10179B LV 10179 B LV10179 B LV 10179B LV 931379 A LV931379 A LV 931379A LV 10179 B LV10179 B LV 10179B
- Authority
- LV
- Latvia
- Prior art keywords
- melphalan
- hydrochloride
- component
- citrate
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878727157A GB8727157D0 (en) | 1987-11-19 | 1987-11-19 | Pharmaceutical formulations |
EP88310805A EP0317281B1 (en) | 1987-11-19 | 1988-11-16 | Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10179A LV10179A (lv) | 1994-10-20 |
LV10179B true LV10179B (en) | 1995-06-20 |
Family
ID=10627252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-93-1379A LV10179B (en) | 1987-11-19 | 1993-12-28 | Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them |
Country Status (22)
Country | Link |
---|---|
US (1) | US4997651A (el) |
EP (1) | EP0317281B1 (el) |
JP (1) | JP2693191B2 (el) |
KR (1) | KR970002607B1 (el) |
AT (1) | ATE83922T1 (el) |
AU (1) | AU619781B2 (el) |
CA (1) | CA1341114C (el) |
DE (1) | DE3877151T2 (el) |
DK (1) | DK172794B1 (el) |
ES (1) | ES2052745T3 (el) |
FI (2) | FI90204C (el) |
GB (1) | GB8727157D0 (el) |
GR (1) | GR3007287T3 (el) |
HK (1) | HK108994A (el) |
HU (3) | HU207286B (el) |
IE (1) | IE63996B1 (el) |
IL (1) | IL88419A (el) |
LV (1) | LV10179B (el) |
NZ (2) | NZ227004A (el) |
PT (1) | PT89028B (el) |
SG (1) | SG73894G (el) |
ZA (1) | ZA888674B (el) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5695751A (en) * | 1993-04-08 | 1997-12-09 | Cornell Research Foundation, Inc. | Enhancing delivery of large neutral amino acid drugs |
US5407672A (en) * | 1993-04-08 | 1995-04-18 | Cornell Research Foundation, Inc. | Enhancing the anti-tumor effect of melphalan with L-amino acid oxidase |
US6020004A (en) * | 1997-04-17 | 2000-02-01 | Amgen Inc. | Biodegradable microparticles for the sustained delivery of therapeutic drugs |
US5980904A (en) * | 1998-11-18 | 1999-11-09 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
GB2386066A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species |
WO2004000229A2 (en) * | 2002-06-24 | 2003-12-31 | Research Development Foundation | Treatment of human multiple myeloma by curcumin |
US7462646B2 (en) | 2003-08-26 | 2008-12-09 | Research Development Foundation | Osteoclastogenesis inhibitors and uses thereof |
US8501818B2 (en) | 2005-03-14 | 2013-08-06 | Ceptaris Therapeutics, Inc. | Stabilized compositions of alkylating agents and methods of using same |
US7872050B2 (en) | 2005-03-14 | 2011-01-18 | Yaupon Therapeutics Inc. | Stabilized compositions of volatile alkylating agents and methods of using thereof |
EP3494960B1 (en) | 2008-03-27 | 2020-11-25 | Helsinn Healthcare SA | Stabilized compositions of alkylating agents and methods of using same |
AR066943A1 (es) * | 2008-06-10 | 2009-09-23 | Eriochem Sa | Una composicion farmaceutica de melfalano |
US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
CN102458114A (zh) * | 2009-05-29 | 2012-05-16 | 锡德克斯药物公司 | 包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法 |
AR077384A1 (es) * | 2010-07-05 | 2011-08-24 | Eriochem Sa | Una formulacion farmaceutica inyectable de melfalano. |
US8921596B2 (en) * | 2010-11-04 | 2014-12-30 | Emcure Pharmaceuticals, Ltd. | Process for the preparation of melphalan hydrochloride |
DK3656393T3 (da) * | 2011-04-28 | 2022-11-14 | Oncopeptides Ab | Lyofiliseret præparat af cytotoksiske dipeptider |
CA2889753C (en) | 2012-10-26 | 2021-03-02 | Oncopeptides Ab | Lyophilized preparations of melphalan flufenamide |
US9963422B2 (en) | 2013-03-11 | 2018-05-08 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the synthesis of melphalan and the hydrochloride salt |
ITMI20130896A1 (it) * | 2013-05-31 | 2014-12-01 | Farmabios Spa | Processo di purificazione di melphalan |
DK3265075T3 (en) | 2015-03-06 | 2019-04-08 | Leadiant Biosciences Sa In Liquidazione | COMBINATION TREATMENT OF MULTIPLE MYELOMA WITH RONEPARSTAT |
WO2017002030A1 (en) * | 2015-06-30 | 2017-01-05 | Leiutis Pharmaceuticals Pvt Ltd | Stable liquid formulations of melphalan |
ES2928931T3 (es) * | 2018-03-29 | 2022-11-23 | Project Pharmaceutics Gmbh | Formulación farmacéutica líquida |
US10682326B1 (en) | 2019-06-03 | 2020-06-16 | Shilpa Medicare Limited | Stable melphalan liquid injectable formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB750155A (en) * | 1953-03-17 | 1956-06-13 | Nat Res Dev | Substituted alanines |
US3032585A (en) * | 1954-12-03 | 1962-05-01 | Nat Res Dev | Process for the production of p-bis-(2-chloroethyl)-aminophenylalanine |
DE1292660B (de) * | 1963-04-24 | 1969-04-17 | Ural Polytechnitscheskij I Im | Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid |
US4029778A (en) * | 1969-01-23 | 1977-06-14 | Aktiebolaget Leo | Cortical steroid nitrogen mustard compositions and treatment therewith |
RO57195A2 (el) * | 1970-11-30 | 1974-09-01 | ||
FR2285855A1 (fr) * | 1974-09-25 | 1976-04-23 | Kohjin Co | Composition therapeutique lyophilisee a base de sel de cyclocytidine et son procede de preparation |
JPS59186924A (ja) * | 1983-04-08 | 1984-10-23 | Kureha Chem Ind Co Ltd | ヒト免疫グロブリン結合抗腫瘍剤 |
US4696814A (en) * | 1985-08-21 | 1987-09-29 | Warner-Lambert Company | Parenteral phenytoin compositions |
JPS62192357A (ja) * | 1986-02-19 | 1987-08-22 | Kureha Chem Ind Co Ltd | N−フタロイル−p−ニトロ−L−フエニルアラニンの製造方法 |
-
1987
- 1987-11-19 GB GB878727157A patent/GB8727157D0/en active Pending
-
1988
- 1988-11-16 EP EP88310805A patent/EP0317281B1/en not_active Expired - Lifetime
- 1988-11-16 AT AT88310805T patent/ATE83922T1/de not_active IP Right Cessation
- 1988-11-16 DE DE8888310805T patent/DE3877151T2/de not_active Expired - Lifetime
- 1988-11-16 ES ES88310805T patent/ES2052745T3/es not_active Expired - Lifetime
- 1988-11-18 KR KR1019880015196A patent/KR970002607B1/ko not_active IP Right Cessation
- 1988-11-18 PT PT89028A patent/PT89028B/pt not_active IP Right Cessation
- 1988-11-18 ZA ZA888674A patent/ZA888674B/xx unknown
- 1988-11-18 US US07/273,227 patent/US4997651A/en not_active Expired - Lifetime
- 1988-11-18 HU HU91335A patent/HU207286B/hu unknown
- 1988-11-18 HU HU885953A patent/HU203197B/hu unknown
- 1988-11-18 AU AU25748/88A patent/AU619781B2/en not_active Expired
- 1988-11-18 HU HU91336A patent/HU206671B/hu unknown
- 1988-11-18 DK DK198806466A patent/DK172794B1/da not_active IP Right Cessation
- 1988-11-18 IE IE344788A patent/IE63996B1/en not_active IP Right Cessation
- 1988-11-18 CA CA000583540A patent/CA1341114C/en not_active Expired - Fee Related
- 1988-11-18 NZ NZ227004A patent/NZ227004A/xx unknown
- 1988-11-18 IL IL88419A patent/IL88419A/xx not_active IP Right Cessation
- 1988-11-18 NZ NZ239867A patent/NZ239867A/en unknown
- 1988-11-18 FI FI885358A patent/FI90204C/fi not_active IP Right Cessation
- 1988-11-18 JP JP63292228A patent/JP2693191B2/ja not_active Expired - Lifetime
-
1992
- 1992-10-15 FI FI924668A patent/FI102275B/fi not_active IP Right Cessation
-
1993
- 1993-03-09 GR GR930400510T patent/GR3007287T3/el unknown
- 1993-12-28 LV LVP-93-1379A patent/LV10179B/en unknown
-
1994
- 1994-06-03 SG SG73894A patent/SG73894G/en unknown
- 1994-10-06 HK HK108994A patent/HK108994A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4997651A (en) | Pharmaceutical formulations | |
JP4192114B2 (ja) | 環式付着阻害剤 | |
JP2928047B2 (ja) | 安定なポルフィマーナトリウム組成物およびその製造方法 | |
CN103209966B (zh) | 6-氟-3-羟基-2-吡嗪甲酰胺的钠盐 | |
EP0067666B1 (en) | Salts of antimicrobial naphthyridine and quinoline compounds and their production | |
JPS60188317A (ja) | 抗健忘症剤 | |
RU2027442C1 (ru) | Вещество, обладающее противоопухолевой активностью | |
BE1001704A3 (fr) | Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique. | |
HU199289B (en) | Process for production of liofilized medical compositions containing derivatives of phenil-quinoline-carbonic acid | |
PH26521A (en) | Pharmaceutical formulation | |
US4322424A (en) | Crystalline glucoconate salt of m-AMSA and compositions containing same | |
KR920006911B1 (ko) | 안정한 피록시캄 주사액 조성물 및 그의 제조방법 | |
HU210876A9 (en) | Arginine derivatives | |
HU183357B (en) | Process for preparing pharmaceutically acceptable 4'-/9-acridinyl-amino/-methansulphone-m-anizidide salts | |
US4626541A (en) | Water soluble salt composition of m-AMSA | |
JPS6165819A (ja) | 有機ゲルマニウム化合物を含有する薬剤組成物 | |
US4946689A (en) | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin | |
JP3406334B2 (ja) | チロシン特異的リン酸化酵素阻害剤及び制癌剤 | |
RU2116081C1 (ru) | Циклические ингибиторы адгезии | |
JPS5813556A (ja) | 新規な光学活性ジペプチド | |
JPH03500781A (ja) | 結晶(5r,6s)‐2‐カルバモイルオキシメチル‐6‐[(1r)‐ヒドロキシエチル]‐2‐ペネム‐カルボン酸及びその医薬処方物 | |
KR970008483B1 (ko) | 신규한 n-4-살리실아미드-2-아미노-6-피페리디노피리미딘 3-옥사이드, 그의 제조방법 및 그를 함유하는 양모제 조성물 | |
JP2002080494A (ja) | 新規な抗脱毛ペプチド | |
JPH03240796A (ja) | ペプタイド誘導体 | |
JPH09328424A (ja) | フェニルプロペン酸誘導体 |